This conference preview with Kathryn Berlacher, MD, MS, and Kristen Campbell, PharmD, highlights the top 6 trials to watch at ACC 2026.
Kathryn Berlacher, MD, MS
Advertisement
Kathryn Berlacher, MD, MS, is the clinical & strategic director of cardiology at UPMC and the chair of ACC 2026.
Articles by Kathryn Berlacher, MD, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Diagnostic Pearls and New Therapies in Connective Tissue Disease, With Michelle Min, MD
2
Rethinking “Type 2”: Inside the 2026 AACE Diabetes Classification Algorithm
3
VIASKIN Peanut Patch Efficacy Holds in Kids With Atopic Comorbidities
4
Fezolinetant Shows No CNS Safety Signal in Pooled Analysis of 3100 Women, With Marla Shapiro, CM
5